Loading insider details...
Beta
Latest Form 4 (Mar 25, 2026): Grant/Award of 37,313 DMRA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 25, 2026 | Damora Therapeutics, Inc. (DMRA) | Grant/Award | 37,313 | n/a |
| Aug 19, 2024 | Blueprint Medicines Corp (BPMC) | Sale | 4,409 | $419.9K |
| May 17, 2024 | Blueprint Medicines Corp (BPMC) | Sale | 2,486 | $266.4K |
| May 10, 2024 | Blueprint Medicines Corp (BPMC) | Exercise/Conversion | 26,363 | $49.3K |
| May 6, 2024 | Blueprint Medicines Corp (BPMC) | Exercise/Conversion | 10,000 | $360.5K |
| Apr 1, 2024 | Blueprint Medicines Corp (BPMC) | Exercise/Conversion | 5,000 | $180.3K |
| Mar 19, 2024 | Blueprint Medicines Corp (BPMC) | Exercise/Conversion | 5,000 | $180.3K |
| Mar 11, 2024 | Blueprint Medicines Corp (BPMC) | Sale | 5,003 | $453.7K |
| Mar 6, 2024 | Blueprint Medicines Corp (BPMC) | Grant/Award | 12,500 | n/a |